These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9778080)

  • 1. An angiographic assessment of alteplase: double-bolus and front-loaded infusion regimens in myocardial infarction. DouBLE Study Investigators. Double Bolus Lysis Efficacy.
    Bleich SD; Adgey AA; McMechan SR; Love TW
    Am Heart J; 1998 Oct; 136(4 Pt 1):741-8. PubMed ID: 9778080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Randomized comparison of coronary thrombolysis achieved with double-bolus reteplase (recombinant plasminogen activator) and front-loaded, accelerated alteplase (recombinant tissue plasminogen activator) in patients with acute myocardial infarction. The RAPID II Investigators.
    Bode C; Smalling RW; Berg G; Burnett C; Lorch G; Kalbfleisch JM; Chernoff R; Christie LG; Feldman RL; Seals AA; Weaver WD
    Circulation; 1996 Sep; 94(5):891-8. PubMed ID: 8790022
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A comparison of continuous infusion of alteplase with double-bolus administration for acute myocardial infarction.
    Continuous Infusion versus Double-Bolus Administration of Alteplase (COBALT) Investigators
    N Engl J Med; 1997 Oct; 337(16):1124-30. PubMed ID: 9340504
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patency trials with reteplase (r-PA): what do they tell us?
    Bode C; Nordt TK; Peter K; Smalling RW; Runge MS; Kübler W
    Am J Cardiol; 1996 Dec; 78(12A):16-9. PubMed ID: 8990406
    [TBL] [Abstract][Full Text] [Related]  

  • 5. More rapid, complete, and stable coronary thrombolysis with bolus administration of reteplase compared with alteplase infusion in acute myocardial infarction. RAPID Investigators.
    Smalling RW; Bode C; Kalbfleisch J; Sen S; Limbourg P; Forycki F; Habib G; Feldman R; Hohnloser S; Seals A
    Circulation; 1995 Jun; 91(11):2725-32. PubMed ID: 7758177
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sixty-minute alteplase protocol: a new accelerated recombinant tissue-type plasminogen activator regimen for thrombolysis in acute myocardial infarction.
    Gulba DC; Tanswell P; Dechend R; Sosada M; Weis A; Waigand J; Uhlich F; Hauck S; Jost S; Rafflenbeul W; Lichtlen PR; Dietz R
    J Am Coll Cardiol; 1997 Dec; 30(7):1611-7. PubMed ID: 9385884
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of 100 mg of double-bolus alteplase in achieving complete perfusion in the treatment of acute myocardial infarction.
    Purvis JA; McNeill AJ; Siddiqui RA; Roberts MJ; McClements BM; McEneaney D; Campbell NP; Khan MM; Webb SW; Wilson CM
    J Am Coll Cardiol; 1994 Jan; 23(1):6-10. PubMed ID: 8277097
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenecteplase: a review of its pharmacology and therapeutic efficacy in patients with acute myocardial infarction.
    Dunn CJ; Goa KL
    Am J Cardiovasc Drugs; 2001; 1(1):51-66. PubMed ID: 14728052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of double bolus urokinase versus front-loaded alteplase regimen for acute myocardial infarction. Thrombolysis in Myocardial Infarction in Korea (TIMIKO) study group.
    Park SJ
    Am J Cardiol; 1998 Sep; 82(6):811-3, A10. PubMed ID: 9761098
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Can we improve on front-loaded alteplase (r-TPA)?
    Aylward P
    Aust N Z J Med; 1998 Aug; 28(4):511-3. PubMed ID: 9777130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coronary recanalization rate after intravenous bolus of alteplase in acute myocardial infarction.
    Tranchesi B; Chamone DF; Cobbaert C; Van de Werf F; Vanhove P; Verstraete M
    Am J Cardiol; 1991 Jul; 68(2):161-5. PubMed ID: 1829574
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Results of the RAPID 1 and RAPID 2 thrombolytic trials in acute myocardial infarction.
    Weaver WD
    Eur Heart J; 1996 Sep; 17 Suppl E():14-20. PubMed ID: 11823998
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Randomized angiographic trial of recombinant tissue-type plasminogen activator (alteplase) in myocardial infarction. RAAMI Study Investigators.
    Carney RJ; Murphy GA; Brandt TR; Daley PJ; Pickering E; White HJ; McDonough TJ; Vermilya SK; Teichman SL
    J Am Coll Cardiol; 1992 Jul; 20(1):17-23. PubMed ID: 1607520
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optimal thrombolytic strategies for acute myocardial infarction--bolus administration.
    McMechan SR; Adgey AA
    QJM; 1998 Nov; 91(11):719-25. PubMed ID: 10024933
    [TBL] [Abstract][Full Text] [Related]  

  • 15. TNK-tissue plasminogen activator compared with front-loaded alteplase in acute myocardial infarction: results of the TIMI 10B trial. Thrombolysis in Myocardial Infarction (TIMI) 10B Investigators.
    Cannon CP; Gibson CM; McCabe CH; Adgey AA; Schweiger MJ; Sequeira RF; Grollier G; Giugliano RP; Frey M; Mueller HS; Steingart RM; Weaver WD; Van de Werf F; Braunwald E
    Circulation; 1998 Dec 22-29; 98(25):2805-14. PubMed ID: 9860780
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a weight-adjusted single-bolus plasminogen activator in patients with myocardial infarction: a double-blind, randomized angiographic trial of lanoteplase versus alteplase.
    den Heijer P; Vermeer F; Ambrosioni E; Sadowski Z; López-Sendón JL; von Essen R; Beaufils P; Thadani U; Adgey J; Pierard L; Brinker J; Davies RF; Smalling RW; Wallentin L; Caspi A; Pangerl A; Trickett L; Hauck C; Henry D; Chew P
    Circulation; 1998 Nov; 98(20):2117-25. PubMed ID: 9815865
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fibrin specificity and procoagulant effect related to the kallikrein-contact phase system and to plasmin generation with double-bolus reteplase and front-loaded alteplase thrombolysis in acute myocardial infarction.
    Hoffmeister HM; Kastner C; Szabo S; Beyer ME; Helber U; Kazmaier S; Baumbach A; Wendel HP; Heller W
    Am J Cardiol; 2000 Aug; 86(3):263-8. PubMed ID: 10922430
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Single-bolus tenecteplase compared with front-loaded alteplase in acute myocardial infarction: the ASSENT-2 double-blind randomised trial.
    ; Van De Werf F; Adgey J; Ardissino D; Armstrong PW; Aylward P; Barbash G; Betriu A; Binbrek AS; Califf R; Diaz R; Fanebust R; Fox K; Granger C; Heikkilä J; Husted S; Jansky P; Langer A; Lupi E; Maseri A; Meyer J; Mlczoch J; Mocceti D; Myburgh D; Oto A; Paolasso E; Pehrsson K; Seabra-Gomes R; Soares-Piegas L; Sùgrue D; Tendera M; Topol E; Toutouzas P; Vahanian A; Verheugt F; Wallentin L; White H
    Lancet; 1999 Aug; 354(9180):716-22. PubMed ID: 10475182
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Randomized coronary patency trial of double-bolus recombinant staphylokinase versus front-loaded alteplase in acute myocardial infarction.
    Vanderschueren S; Dens J; Kerdsinchai P; Desmet W; Vrolix M; De Man F; Van den Heuvel P; Hermans L; Collen D; Van de Werf F
    Am Heart J; 1997 Aug; 134(2 Pt 1):213-9. PubMed ID: 9313600
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion. Importance of early and complete infarct artery reperfusion. GUSTO-I Investigators.
    Simes RJ; Topol EJ; Holmes DR; White HD; Rutsch WR; Vahanian A; Simoons ML; Morris D; Betriu A; Califf RM
    Circulation; 1995 Apr; 91(7):1923-8. PubMed ID: 7895348
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.